Report cover image

Global China PD-L1 and PIK3CA Testing Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 194 Pages
SKU # APRC20359415

Description

Summary

According to APO Research, the global China PD-L1 and PIK3CA Testing market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the China PD-L1 and PIK3CA Testing market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the China PD-L1 and PIK3CA Testing market include Agilent Technologies, EntroGen, QIAGEN, Amoy Diagnostics, Roche and ACCB Biotech, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for China PD-L1 and PIK3CA Testing, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of China PD-L1 and PIK3CA Testing, also provides the value of main regions and countries. Of the upcoming market potential for China PD-L1 and PIK3CA Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the China PD-L1 and PIK3CA Testing revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global China PD-L1 and PIK3CA Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global China PD-L1 and PIK3CA Testing company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
China PD-L1 and PIK3CA Testing Segment by Company

Agilent Technologies
EntroGen
QIAGEN
Amoy Diagnostics
Roche
ACCB Biotech
China PD-L1 and PIK3CA Testing Segment by Type

PD-L1 Testing
PIK3CA Testing
China PD-L1 and PIK3CA Testing Segment by Application

Hospital
Diagnostic Center
Others
China PD-L1 and PIK3CA Testing Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global China PD-L1 and PIK3CA Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the China PD-L1 and PIK3CA Testing key companies, revenue, market share, and recent developments.
3. To split the China PD-L1 and PIK3CA Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions China PD-L1 and PIK3CA Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify China PD-L1 and PIK3CA Testing significant trends, drivers, influence factors in global and regions.
6. To analyze China PD-L1 and PIK3CA Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global China PD-L1 and PIK3CA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of China PD-L1 and PIK3CA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of China PD-L1 and PIK3CA Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global China PD-L1 and PIK3CA Testing industry.
Chapter 3: Detailed analysis of China PD-L1 and PIK3CA Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of China PD-L1 and PIK3CA Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of China PD-L1 and PIK3CA Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global China PD-L1 and PIK3CA Testing Market Size, 2020 VS 2024 VS 2031
1.3 Global China PD-L1 and PIK3CA Testing Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 China PD-L1 and PIK3CA Testing Market Dynamics
2.1 China PD-L1 and PIK3CA Testing Industry Trends
2.2 China PD-L1 and PIK3CA Testing Industry Drivers
2.3 China PD-L1 and PIK3CA Testing Industry Opportunities and Challenges
2.4 China PD-L1 and PIK3CA Testing Industry Restraints
3 China PD-L1 and PIK3CA Testing Market by Company
3.1 Global China PD-L1 and PIK3CA Testing Company Revenue Ranking in 2024
3.2 Global China PD-L1 and PIK3CA Testing Revenue by Company (2020-2025)
3.3 Global China PD-L1 and PIK3CA Testing Company Ranking (2023-2025)
3.4 Global China PD-L1 and PIK3CA Testing Company Manufacturing Base and Headquarters
3.5 Global China PD-L1 and PIK3CA Testing Company Product Type and Application
3.6 Global China PD-L1 and PIK3CA Testing Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global China PD-L1 and PIK3CA Testing Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 China PD-L1 and PIK3CA Testing Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 China PD-L1 and PIK3CA Testing Market by Type
4.1 China PD-L1 and PIK3CA Testing Type Introduction
4.1.1 PD-L1 Testing
4.1.2 PIK3CA Testing
4.2 Global China PD-L1 and PIK3CA Testing Sales Value by Type
4.2.1 Global China PD-L1 and PIK3CA Testing Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global China PD-L1 and PIK3CA Testing Sales Value by Type (2020-2031)
4.2.3 Global China PD-L1 and PIK3CA Testing Sales Value Share by Type (2020-2031)
5 China PD-L1 and PIK3CA Testing Market by Application
5.1 China PD-L1 and PIK3CA Testing Application Introduction
5.1.1 Hospital
5.1.2 Diagnostic Center
5.1.3 Others
5.2 Global China PD-L1 and PIK3CA Testing Sales Value by Application
5.2.1 Global China PD-L1 and PIK3CA Testing Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global China PD-L1 and PIK3CA Testing Sales Value by Application (2020-2031)
5.2.3 Global China PD-L1 and PIK3CA Testing Sales Value Share by Application (2020-2031)
6 China PD-L1 and PIK3CA Testing Regional Value Analysis
6.1 Global China PD-L1 and PIK3CA Testing Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global China PD-L1 and PIK3CA Testing Sales Value by Region (2020-2031)
6.2.1 Global China PD-L1 and PIK3CA Testing Sales Value by Region: 2020-2025
6.2.2 Global China PD-L1 and PIK3CA Testing Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America China PD-L1 and PIK3CA Testing Sales Value (2020-2031)
6.3.2 North America China PD-L1 and PIK3CA Testing Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe China PD-L1 and PIK3CA Testing Sales Value (2020-2031)
6.4.2 Europe China PD-L1 and PIK3CA Testing Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific China PD-L1 and PIK3CA Testing Sales Value (2020-2031)
6.5.2 Asia-Pacific China PD-L1 and PIK3CA Testing Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America China PD-L1 and PIK3CA Testing Sales Value (2020-2031)
6.6.2 South America China PD-L1 and PIK3CA Testing Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa China PD-L1 and PIK3CA Testing Sales Value (2020-2031)
6.7.2 Middle East & Africa China PD-L1 and PIK3CA Testing Sales Value Share by Country, 2024 VS 2031
7 China PD-L1 and PIK3CA Testing Country-level Value Analysis
7.1 Global China PD-L1 and PIK3CA Testing Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global China PD-L1 and PIK3CA Testing Sales Value by Country (2020-2031)
7.2.1 Global China PD-L1 and PIK3CA Testing Sales Value by Country (2020-2025)
7.2.2 Global China PD-L1 and PIK3CA Testing Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.3.2 USA China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.3.3 USA China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.4.2 Canada China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.5.2 Mexico China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.6.2 Germany China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.7.2 France China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.7.3 France China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.8.2 U.K. China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.9.2 Italy China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.10.2 Spain China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.11.2 Russia China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.14.2 China China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.14.3 China China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.15.2 Japan China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.16.2 South Korea China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.17.2 India China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.17.3 India China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.18.2 Australia China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.20.2 Brazil China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.21.2 Argentina China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.22.2 Chile China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.23.2 Colombia China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.24.2 Peru China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.26.2 Israel China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.27.2 UAE China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.28.2 Turkey China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.29.2 Iran China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt China PD-L1 and PIK3CA Testing Sales Value Growth Rate (2020-2031)
7.30.2 Egypt China PD-L1 and PIK3CA Testing Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt China PD-L1 and PIK3CA Testing Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Agilent Technologies
8.1.1 Agilent Technologies Comapny Information
8.1.2 Agilent Technologies Business Overview
8.1.3 Agilent Technologies China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
8.1.4 Agilent Technologies China PD-L1 and PIK3CA Testing Product Portfolio
8.1.5 Agilent Technologies Recent Developments
8.2 EntroGen
8.2.1 EntroGen Comapny Information
8.2.2 EntroGen Business Overview
8.2.3 EntroGen China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
8.2.4 EntroGen China PD-L1 and PIK3CA Testing Product Portfolio
8.2.5 EntroGen Recent Developments
8.3 QIAGEN
8.3.1 QIAGEN Comapny Information
8.3.2 QIAGEN Business Overview
8.3.3 QIAGEN China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
8.3.4 QIAGEN China PD-L1 and PIK3CA Testing Product Portfolio
8.3.5 QIAGEN Recent Developments
8.4 Amoy Diagnostics
8.4.1 Amoy Diagnostics Comapny Information
8.4.2 Amoy Diagnostics Business Overview
8.4.3 Amoy Diagnostics China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
8.4.4 Amoy Diagnostics China PD-L1 and PIK3CA Testing Product Portfolio
8.4.5 Amoy Diagnostics Recent Developments
8.5 Roche
8.5.1 Roche Comapny Information
8.5.2 Roche Business Overview
8.5.3 Roche China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
8.5.4 Roche China PD-L1 and PIK3CA Testing Product Portfolio
8.5.5 Roche Recent Developments
8.6 ACCB Biotech
8.6.1 ACCB Biotech Comapny Information
8.6.2 ACCB Biotech Business Overview
8.6.3 ACCB Biotech China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
8.6.4 ACCB Biotech China PD-L1 and PIK3CA Testing Product Portfolio
8.6.5 ACCB Biotech Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.